BICO Group AB (publ) (STO:BICO)

Market Cap	2.57B
Revenue (ttm)	1.95B
Net Income (ttm)	-5.50M
Shares Out	70.57M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	178,822
Average Volume	243,828
Open	37.58
Previous Close	37.62
Day's Range	36.16 - 37.58
52-Week Range	28.18 - 56.55
Beta	2.52
RSI	44.37
Earnings Date	Apr 29, 2025

About BICO Group AB

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end prod...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 726
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2024, BICO Group AB's revenue was 1.95 billion, a decrease of -19.07% compared to the previous year's 2.40 billion. Losses were -5.50 million, -99.72% less than in 2023.